Universitad Major de S. Andres, La Paz, Bolivia Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2008
NCT01182792
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Adelina Pellicer

Active Ingredients

Drugs in Phase 2 Trials (1)

dobutamine (dobutrex) (1 trial)

Drugs in Other Trials (2)

vitamin c (1 trial)

vitamin e (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3